Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2020

Jan 23, 2020

31873_dirs_2020-01-23_b97a11d0-3b49-4d95-9dd2-52196631a28c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-01-21

Reporting Person: Weiss Patrick (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-21 Common Stock S 598 $22.238 Disposed 95628 Direct
2020-01-21 Common Stock S 3491 $22.298 Disposed 92137 Direct
2020-01-22 Common Stock S 435 $22.227 Disposed 91702 Direct
2020-01-22 Common Stock S 163 $23.060 Disposed 91539 Direct
2020-01-22 Common Stock S 2468 $22.216 Disposed 89071 Direct
2020-01-22 Common Stock S 1023 $23.055 Disposed 88048 Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.03 to $22.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.04 to $22.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.85 to $22.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.91 to $23.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.83 to $22.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.87 to $23.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.